MedTrace Logo

Neuroendocrine Mechanisms of Growth and Body Composition in Preterm and Term Infants

NCT00833222 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2017-12-26

No results posted yet for this study

Summary

The purpose of this study is to test the feasibility of measuring body composition by air displacement plethysmography (ADP) in rapidly growing, medically stable late gestation \[32-35 weeks post-menstrual age (PMA)\] premature infants.

Conditions

  • Premature Birth

Sponsors & Collaborators

Principal Investigators

  • Laurie Moyer-Mileur, PhD · University of Utah

  • Kristine Jordan, MPH, PhD · University of Utah

Eligibility

Min Age
31 Weeks
Max Age
42 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00833222 on ClinicalTrials.gov